Men with low-risk prostate cancer on active surveillance whose tumors are upgraded after a biopsy might not have to rush into surgery, according to new research.
The men in this study had localized low-risk prostate cancer — a Gleason score of 3 + 3 or lower and a clinical stage of T1 or T2. All had a tumor upgrade while being managed with active surveillance
The majority of the men who chose to remain on active surveillance after a tumor upgrade, rather than undergo immediate treatment, had no further progression of tumor grade.